N. Zuma

发表

Modelling CD4+ count over time in HIV positive patients initiated on HAART in South Africa using linear mixed models.

N. Zuma, 2009 .

HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services.

J. Frohlich, A. Kharsany, M. Mlotshwa, 2012, World health & population.

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

J. Mascola, L. Morris, J. Ledgerwood, 2019, BMJ Open.

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

M. Baum, S. A. Abdool Karim, J. Moss, 2022, BMJ Open.

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial

J. Mascola, L. Morris, J. Ledgerwood, 2020, BMJ Open.

Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa

K. Naidoo, H. Dawood, R. Hassan-Moosa, 2018, BMC Infectious Diseases.

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

N. Garrett, L. Bekker, I. Sanne, 2023, BMJ medicine.

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

R. Koup, L. Morris, P. Moore, 2023, BMJ open.

Accessing success through the Writing Centres at a University of Technology

Nonhlanhla Zuma, Tosin Popoola, Livingstone Makondo, 2016 .